Carboplatin in combination with paclitaxel in advanced ovarian cancer : dose determination and pharmacokinetic and pharmacodynamics interactionsCALVERT, A. H; BODDY, A; PROCTOR, M et al.Seminars in oncology. 1995, Vol 22, Num 5, pp 91-98, issn 0093-7754, SUP12Conference Paper

An phase II study of ifosfamide and a_2b-interferon in advanced non-small-cell lung cancerLIND, M. J; GOMM, S; SIMMONDS, A. P et al.Cancer chemotherapy and pharmacology. 1991, Vol 28, Num 2, pp 142-144, issn 0344-5704Article

A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancerLIND, M. J; CANTWELL, B. M. J; MILLWARD, M. J et al.British journal of cancer. 1992, Vol 65, Num 4, pp 621-623, issn 0007-0920Article

Cyclosporin associated demyelination following allogeneic bone marrow transplantationLIND, M. J; MCWILLIAM, L; JIP, J et al.Hematological oncology. 1989, Vol 7, Num 1, pp 49-52, issn 0278-0232Article

The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivoLIND, M. J; MCGOWN, A. T; HADFIELD, J. A et al.Biochemical pharmacology. 1989, Vol 38, Num 11, pp 1835-1840, issn 0006-2952Article

The role of postoperative alkylating agent therapy in early-stage epithelial ovarian cancerMACKINTOSCH, J; BUCKLEY, C. H; TINDALL, V. R et al.British journal of obstetrics and gynaecology (Print). 1989, Vol 96, Num 3, pp 353-357, issn 0306-5456Article

Cyclooxygenase-2 expression predicts survival in malignant pleural mesotheliomaO'KANE, S. L; CAWKWELL, L; CAMPBELL, A et al.European journal of cancer (1990). 2005, Vol 41, Num 11, pp 1645-1648, issn 0959-8049, 4 p.Article

Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisationBERRIEMAN, H. K; ASHMAN, J. N. E; COWEN, M. E et al.British journal of cancer. 2004, Vol 90, Num 4, pp 900-905, issn 0007-0920, 6 p.Article

A phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acidLAOHAVINIJ, S; WEDGE, S. R; GUMBRELL, L et al.Investigational new drugs. 1996, Vol 14, Num 3, pp 325-335, issn 0167-6997Article

The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancerLIND, M. J; GUMBRELL, L; CANTWELL, B. M. J et al.British journal of cancer. 1995, Vol 71, Num 3, pp 610-613, issn 0007-0920Article

Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distributionLIND, M. J; MARGISON, J. M; CERNY, T et al.Cancer chemotherapy and pharmacology. 1989, Vol 25, Num 2, pp 139-142, issn 0344-5704Article

Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancerANDERSON, H; WAGSTAFF, J; CROWTHER, D et al.European journal of cancer & clinical oncology. 1988, Vol 24, Num 9, pp 1471-1479, issn 0277-5379Article

Neoadjuvant chemotherapy in breast cancer : early response prediction with quantitative MR imaging and spectroscopyMANTON, D. J; CHATURVEDI, A; HUBBARD, A et al.British journal of cancer. 2006, Vol 94, Num 3, pp 427-435, issn 0007-0920, 9 p.Article

A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancerMILES, D. W; SMITH, I. E; COLEMAN, R. E et al.European journal of cancer (1990). 2001, Vol 37, Num 11, pp 1366-1371, issn 0959-8049Article

Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancerMILLWARD, M. J; NEWELL, D. R; SIMMONDS, D et al.Cancer chemotherapy and pharmacology. 1995, Vol 37, Num 1-2, pp 161-167, issn 0344-5704Article

Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinomaMURPHY, D; LIND, M. J; PRENDIVILLE, J et al.European journal of cancer (1990). 1992, Vol 28A, Num 4-5, pp 870-872, issn 0959-8049Article

The effect of route of administration and fractionation of dose on the metabolism of ifosfamideLIND, M. J; ROBERTS, H. L; THATCHER, N et al.Cancer chemotherapy and pharmacology. 1990, Vol 26, Num 2, pp 105-111, issn 0344-5704, 7 p.Article

Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinomaLIND, M. J; MARGISON, J. M; CERNY, T et al.Cancer research (Baltimore). 1989, Vol 49, Num 3, pp 753-757, issn 0008-5472Article

Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer: from the Manchester lung tumour groupTHATCHER, N; SMITH, D. B; LIND, M. J et al.Cancer. 1988, Vol 61, Num 1, pp 14-18, issn 0008-543XArticle

Chromosomal alterations in breast cancer revealed by multicolour fluorescence in situ hybridizationWATSON, M. B; BAHIA, H; ASHMAN, J. N. E et al.International journal of oncology. 2004, Vol 25, Num 2, pp 277-283, issn 1019-6439, 7 p.Article

Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumoursTHOMAS, H. D; LIND, M. J; FORD, J et al.Cancer chemotherapy and pharmacology. 2000, Vol 45, Num 4, pp 284-290, issn 0344-5704Article

A phase I and pharmacokinetic study of LY231514, the multitargeted antifolateMCDONALD, A. C; VASEY, P. A; CALVERT, A. H et al.Clinical cancer research. 1998, Vol 4, Num 3, pp 605-610, issn 1078-0432Article

O⁶-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanomaMIDDLETON, M. R; LUNN, J. M; NEWLANDS, E. S et al.British journal of cancer. 1998, Vol 78, Num 9, pp 1199-1202, issn 0007-0920Article

Comparative intraperitoneal pharmacokinetics of three platinum anaologuesLIND, M. J; MURPHY, D. J; SHARMA, H et al.Cancer chemotherapy and pharmacology. 1991, Vol 28, Num 4, pp 315-317, issn 0344-5704Article

The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusionRADFORD, J. A; MARGISON, J. M; SWINDELL, R et al.Journal of cancer research and clinical oncology. 1991, Vol 117, pp S154-S156, issn 0171-5216, SUP4Conference Paper